Want to see OTLC full AI Analyst Report?
Oncotelic Therapeutics (OTLC) Financial Statements
Oncotelic Therapeutics Financial Overview
Oncotelic Therapeutics's market cap is currently $7.48M. The company's EPS TTM is $0.59; its P/E ratio is 0.03; Oncotelic Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Dec 23 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 70.00K | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 70.00K | $ -12.84K | $ -61.51K |
| Operating Income | $ -3.19M | $ -3.58B | $ -6.65M | $ -9.72M | $ -9.13M |
| EBITDA | $ 361.46M | $ -3.80M | $ -6.86M | $ -5.60M | $ -9.06M |
| Net Income | $ 249.28M | $ -4.52B | $ -7.90M | $ 17.82M | $ -11.39M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 88.86K | $ 86.13K | $ 170.41K | $ 241.45K | $ 568.77K |
| Total Assets | $ 393.09M | $ 26.68M | $ 30.01M | $ 36.12M | $ 23.61M |
| Total Debt | $ 13.91M | $ 13.09M | $ 12.57M | $ 11.26M | $ 8.99M |
| Net Debt | $ 13.82M | $ 13.00M | $ 12.40M | $ 11.02M | $ 8.42M |
| Total Liabilities | $ 131.36M | $ 19.20M | $ 18.40M | $ 16.92M | $ 15.45M |
| Stockholders' Equity | $ 262.76M | $ 8.25M | $ 12.13M | $ 19.41M | $ 7.96M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.38M | $ -740.27K | $ -1.32M | $ -1.45M | $ -4.43M |
| Operating Cash Flow | $ -1.38M | $ -740.27K | $ -1.32M | $ -1.45M | $ -4.43M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 1.39M | $ 656.00K | $ 1.25M | $ 1.13M | $ 4.53M |
Currency in USD